SUBSCRIBE
SUBSCRIBE
News   Policy

Human Genome Sciences, Inc. to Seek Hepatitis Drug Approval in Q4

October 19, 2009 | 
1 min read
Bookmark and Share

Reuters -- Human Genome Sciences Inc and its partner Novartis will seek approval for their experimental hepatitis C drug in the fourth quarter, Human Genome said on Monday.
Regulatory
MORE ON THIS TOPIC
Legal battle lawsuit concept as two justice scales hitting each other as a justice court fight symbol representing a lawyer or attorney representation services with 3D illustration elements.
Legal
Court Rejects Two Moderna Defenses in mRNA Vaccine Patent Row With Arbutus
February 18, 2026
 · 
2 min read
 · 
Tristan Manalac
Podcast
Modernagate Fallout, Disc’s Rejection, Compass’ Psilocybin Data, CDC’s Lost Leaders
February 18, 2026
 · 
1 min read
 · 
Heather McKenzie
illustration of doubtful man thinks whether to jump to the other side of the mountain, dilemma concept
Rare disease
Disc’s Regulatory Comeback Plan for Rejected Drug Relies on Old FDA Leadership
February 17, 2026
 · 
3 min read
 · 
Annalee Armstrong
Jim O'Neill
CDC
CDC Left Leaderless Again After Acting Director Departs HHS
February 16, 2026
 · 
1 min read
 · 
Tristan Manalac